(Circulation. 2008;118:e69.)
© 2008 American Heart Association, Inc.
Correspondence |
Pierre Fabre Research Center, Cardiovascular Diseases II Division, Castres, France
We read with a great interest the article by den Ruijter et al,1 which showed that acute application of
3-polyunsaturated fatty acids (DHA and EPA) reduced action potential duration and decreased diastolic and systolic intracellular calcium in myocytes from pathological hearts explanted from rabbits and humans. Consequently,
3-polyunsaturated fatty acids abolished triggered activity and reduced the number of delayed afterdepolarizations and calcium levels after transients.
The purpose of our letter is to point out that a major mechanism is missing from those proposed by the authors: inhibition by
3-polyunsaturated fatty acids of the persistent sodium current. In contrast to the well-known rapid sodium channels that activate and inactivate very quickly, a different mode of gating has been reported. Channels that fail to inactivate completely produce a late or persistent sodium current that is responsible for a long-lasting influx of Na+, which is converted in Ca2+ overload through the activation of the reverse mode of the Na+–Ca2+ exchanger. Persistent sodium current (INa) amplitude is increased in patients with an history of cardiac ischemia2 and in some patients with mutations in the SCN5A gene. Therefore, enhancement of persistent INa is observed and is associated with cellular damages and left ventricular dysfunction in a variety of pathological states, including heart failure.3,4 It has now become apparent that persistent INa plays an important role in the genesis of ischemia-induced ventricular damages and also in arrhythmias observed in failing hearts and that persistent INa represents an attractive target to focus on to provide protection from Na+-induced Ca2+ overload. We previously reported5 that DHA and EPA, in a same range of concentration used in the study by den Ruijter et al,1 concentration-dependently reduced the persistent INa artificially induced with veratridine, as well as the one involved in LQT3 syndrome.
We do not claim that inhibition of persistent INa by
3-polyunsaturated fatty acids is the unique mechanism to prevent triggered activity in myocytes, but we strongly believe that this effect constitutes a key mechanism for the reduction of the abnormalities of calcium homeostasis in failing heart.
| Acknowledgments |
|---|
None.
| References |
|---|
|
|
|---|
2. Saint DA. The role of the persistent Na+ current during cardiac ischemia and hypoxia. J Cardiovasc Electrophysiol. 2006; 17: S96–S103.[CrossRef][Medline] [Order article via Infotrieve]
3. Undrovinas AI, Maltsev VA, Sabbath HN. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci. 1999; 55: 494–505.[CrossRef][Medline] [Order article via Infotrieve]
4. Valdivia CR, Chu WW, Pu J, Foell JD, Haworth RA, Wolff MR, Kamp TJ, Makielski JC. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol. 2005; 38: 475–483.[CrossRef][Medline] [Order article via Infotrieve]
5. Pignier C, Revenaz C, Rauly-Lestienne I, Cussac D, Delhon A, Gardette J, Le Grand B. Direct protective effects of poly-unsaturated fatty acids, DHA and EPA, against activation of cardiac late sodium current: a mechanism for ischemia selectivity. Basic Res Cardiol. 2007; 102: 553–564.[CrossRef][Medline] [Order article via Infotrieve]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |